List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #8,941 to #8,990.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. CDRHCenter for Devices and Radiological Health
  2. CDTDeep vein thrombosis invasive therapy
  3. CD 1aGroup 1 CD1
  4. CD infectionClostridium difficile infection
  5. CEDCamurati-Engelmann disease
  6. CEDARSComprehensive Evaluation Of Defibrillators And Resuscitative Shock
  7. CEEVTick-borne encephalitis
  8. CEF regimenFEC regimen
  9. CELLCost Effectiveness Of Lipid Lowering Study
  10. CELLOBarrett's esophagus
  11. CEOSCongenital Esotropia Observational Study
  12. CEPCep
  13. CERCLASuperfund
  14. CESCES (Disambiguation page)
  15. CETPCholesterylester transfer protein
  16. CETP InhibitorsTorcetrapib
  17. CEVCalifornia encephalitis virus
  18. CE virusCalifornia encephalitis virus
  19. CFCystic fibrosis
  20. CFACraniofacial anomalies
  21. CFCCardiofaciocutaneous syndrome
  22. CFRCoronary flow reserve
  23. CFSChronic fatigue syndrome
  24. CFTRCystic fibrosis transmembrane conductance regulator
  25. CFTR geneCFTR (gene)
  26. CF ViteMultivitamin
  27. CGDChronic granulomatous disease
  28. CGG trinucleotide repeatTrinucleotide repeat disorder
  29. CGHComparative genomic hybridization
  30. CGMPCyclic guanosine monophosphate
  31. CGPMGeneral Conference on Weights and Measures
  32. CGRPCalcitonin gene-related peptide
  33. CGSCentimetre gram second system of units
  34. CHA2-DS2-VASc scoreCHA2DS2-VASc Score
  35. CHA2DS2-VASCCHA2DS2-VASc Score
  36. CHA2DS2-VASc scoreCHA2DS2-VASc Score
  37. CHADSCHADS Score
  38. CHADS2CHADS Score
  39. CHADS2 ScoreCHADS Score
  40. CHADS ScoreCHADS2 score
  41. CHADS scoreCHADS2 score
  42. CHADs ScoreCHADS2 score
  43. CHAMPIONSControlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance
  44. CHAMPSControlled High-Risk Subjects Avonex Ms Prevention Study
  45. CHAPSOCHAPS detergent
  46. CHARGE AssociationCHARGE syndrome
  47. CHARISMAClopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
  48. CHARMCandesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
  49. CHARM Added TrialCandesartan In Heart Failure—Added Trial
  50. CHARM Alternative TrialCandesartan In Heart Failure—Alternative Trial

View ( | ) (20 | 50 | 100 | 250 | 500)